154 related articles for article (PubMed ID: 26036759)
1. Clinical significance of CUL4A in human prostate cancer.
Liu G; Zhu Z; Lang F; Li B; Gao D
Tumour Biol; 2015 Nov; 36(11):8553-8. PubMed ID: 26036759
[TBL] [Abstract][Full Text] [Related]
2. CUL4A is overexpressed in human pituitary adenomas and regulates pituitary tumor cell proliferation.
Xu Y; Wang Y; Ma G; Wang Q; Wei G
J Neurooncol; 2014 Feb; 116(3):625-32. PubMed ID: 24420924
[TBL] [Abstract][Full Text] [Related]
3. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
Li X; Xu R; Liu H; Fang K
Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
[TBL] [Abstract][Full Text] [Related]
4. High Expressions of CUL4A and TP53 in Colorectal Cancer Predict Poor Survival.
Li C; Bu J; Liao Y; Zhang J; Han J; Zhang H; Xing H; Li Z; Wu H; Liang L; Wang M; Qin W; Yang T
Cell Physiol Biochem; 2018; 51(6):2829-2842. PubMed ID: 30562757
[TBL] [Abstract][Full Text] [Related]
5. CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.
Pan Y; Wang B; Yang X; Bai F; Xu Q; Li X; Gao L; Ma C; Liang X
Sci Rep; 2015 Nov; 5():17006. PubMed ID: 26593394
[TBL] [Abstract][Full Text] [Related]
6. Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway.
Deng J; Lei W; Xiang X; Zhang L; Lei J; Gong Y; Song M; Wang Y; Fang Z; Yu F; Feng M; Sun Z; Chen J; Zhan Z; Xiong J
Oncotarget; 2016 Mar; 7(9):10037-50. PubMed ID: 26840256
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of CUL4A inhibits invasion and induces apoptosis in osteosarcoma cells.
Song J; Zhang J; Shao J
Int J Immunopathol Pharmacol; 2015 Jun; 28(2):263-9. PubMed ID: 26055549
[TBL] [Abstract][Full Text] [Related]
8. CUL4A overexpression enhances lung tumor growth and sensitizes lung cancer cells to erlotinib via transcriptional regulation of EGFR.
Wang Y; Zhang P; Liu Z; Wang Q; Wen M; Wang Y; Yuan H; Mao JH; Wei G
Mol Cancer; 2014 Nov; 13():252. PubMed ID: 25413624
[TBL] [Abstract][Full Text] [Related]
9. CUL4A regulates endometrial cancer cell proliferation, invasion and migration by interacting with CSN6.
Wang X; Chen T
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179082
[TBL] [Abstract][Full Text] [Related]
10. CUL4A functions as an oncogene in ovarian cancer and is directly regulated by miR-494.
Han X; Fang Z; Wang H; Jiao R; Zhou J; Fang N
Biochem Biophys Res Commun; 2016 Nov; 480(4):675-681. PubMed ID: 27983981
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer.
Ren S; Xu C; Cui Z; Yu Y; Xu W; Wang F; Lu J; Wei M; Lu X; Gao X; Liang Y; Mao JH; Sun Y
J Mol Med (Berl); 2012 Oct; 90(10):1121-32. PubMed ID: 22422151
[TBL] [Abstract][Full Text] [Related]
12. Jak-STAT3 pathway triggers DICER1 for proteasomal degradation by ubiquitin ligase complex of CUL4A(DCAF1) to promote colon cancer development.
Ren W; Shen S; Sun Z; Shu P; Shen X; Bu C; Ai F; Zhang X; Tang A; Tian L; Li G; Li X; Ma J
Cancer Lett; 2016 Jun; 375(2):209-220. PubMed ID: 26965998
[TBL] [Abstract][Full Text] [Related]
13. CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression.
Zhao M; Qi M; Li X; Hu J; Zhang J; Jiao M; Bai X; Peng X; Han B
Prostate; 2019 Apr; 79(5):480-488. PubMed ID: 30609075
[TBL] [Abstract][Full Text] [Related]
14. Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone.
Cao PP; Chen WJ; Pang HL; Shen WW; Xue P; Duan L; Xu YX; Liu LL; Zhang HL
Oncol Rep; 2020 Feb; 43(2):662-670. PubMed ID: 31894344
[TBL] [Abstract][Full Text] [Related]
15. Investigation of the role of cullin 4A overexpression in human liver cancer.
Chen G; Zhao X; Tan Z; Wang D; Luo D; Zhang P; Cao J; Wang F; Liu Q; Li L
Mol Med Rep; 2018 Sep; 18(3):2531-2540. PubMed ID: 30015884
[TBL] [Abstract][Full Text] [Related]
16. CUL4A as a marker and potential therapeutic target in multiple myeloma.
Yang Y; Wang S; Li J; Qi S; Zhang D
Tumour Biol; 2017 Jul; 39(7):1010428317703923. PubMed ID: 28677427
[TBL] [Abstract][Full Text] [Related]
17. Altered miRNA expression in high-fat diet-induced prostate cancer progression.
Nara T; Narita S; Mingguo H; Yoshioka T; Koizumi A; Numakura K; Tsuruta H; Maeno A; Saito M; Inoue T; Tsuchiya N; Satoh S; Habuchi T
Carcinogenesis; 2016 Dec; 37(12):1129-1137. PubMed ID: 27915273
[TBL] [Abstract][Full Text] [Related]
18. Cullin 4A is associated with epithelial to mesenchymal transition and poor prognosis in perihilar cholangiocarcinoma.
Zhang TJ; Xue D; Zhang CD; Zhang ZD; Liu QR; Wang JQ
World J Gastroenterol; 2017 Apr; 23(13):2318-2329. PubMed ID: 28428711
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
Yin H; Sheng Z; Zhang X; Du Y; Qin C; Liu H; Dun Y; Wang Q; Jin C; Zhao Y; Xu T
Oncol Rep; 2017 Feb; 37(2):1045-1051. PubMed ID: 27922675
[TBL] [Abstract][Full Text] [Related]
20. CUL4A overexpression as an independent adverse prognosticator in intrahepatic cholangiocarcinoma.
Huang G-; Liu TT; Weng SW; You HL; Wei YC; Chen CH; Eng HL; Huang WT
BMC Cancer; 2017 Jun; 17(1):395. PubMed ID: 28576144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]